Delivery Order SPE2DB20D7066-SPE2DB25FC4VB
- Not listed
- The Defense Logistics Agency awarded a $2,366.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for the procurement of Sucralfate 1 GM/10 ML Suspension in a 420 ML quantity. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity, with a contract value of $1,096.68. This firm fixed price delivery order is set to be completed by September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, reflecting the company's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity, with a ceiling value of $2,107.58. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for completion by August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,071.90 to AmerisourceBergen Drug Corp for the supply of Sucralfate 1 GM tablets (100 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension 420 ML, a medication used to treat stomach and duodenal ulcers. The contract has a ceiling value of $3,074.16 and runs through March 26, 2025. This is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition....
- This is a delivery order under Contract SPE2DX15D1053 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,562,782,604 units of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles, with a firm fixed price ceiling of $3,274.80. The contract has an ultimate completion date of November 13, 2023. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov)...
- The Defense Logistics Agency awarded a $2,290.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for sucralfate oral suspension. The contract calls for the delivery of 420 milliliters of sucralfate 1 gram per 10 milliliters oral suspension to a facility in Conshohocken, Pennsylvania. Performance is required between September 28 and 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $2,227.03, is for the supply of 4,565,891,255 units of Sucralfate 1 GM/10 ML Suspension in 420ML containers. The contract has an ultimate completion date of September 23, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
- This federal contract award, valued at $1,728.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEXH2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is a delivery order for the supply of 420 ml bottles of 1 gram/10 ml Sucralfate suspension. The contract has a firm fixed price of $2,357.40 and an ultimate completion date of June 17, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides medical products and supplies to federal government agencies,...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4VBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,068.80 to AmerisourceBergen Drug Corp for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity. This competitively awarded, non-set-aside contract was executed on September 18, 2025, with an ultimate completion date of September 19, 2025, and employs firm fixed price terms. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Sucralfate, a medication used for gastrointestinal ulcer treatment, falls within the extensive catalog of pharmaceuticals and medical supplies that AmerisourceBergen delivers through its DLA contract to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/18/25 |